These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 17204718

  • 1. Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care.
    Israel O, Kuten A.
    J Nucl Med; 2007 Jan; 48 Suppl 1():28S-35S. PubMed ID: 17204718
    [Abstract] [Full Text] [Related]

  • 2. Monitoring cancer treatment with PET/CT: does it make a difference?
    Weber WA, Figlin R.
    J Nucl Med; 2007 Jan; 48 Suppl 1():36S-44S. PubMed ID: 17204719
    [Abstract] [Full Text] [Related]

  • 3. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
    Kasamon YL, Jones RJ, Wahl RL.
    J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
    [Abstract] [Full Text] [Related]

  • 4. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U, Even-Sapir E.
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [Abstract] [Full Text] [Related]

  • 5. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer.
    Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W.
    Eur J Radiol; 2010 Feb; 73(2):294-9. PubMed ID: 19181468
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
    Guo H, Zhu H, Xi Y, Zhang B, Li L, Huang Y, Zhang J, Fu Z, Yang G, Yuan S, Yu J.
    J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
    [Abstract] [Full Text] [Related]

  • 7. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
    Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Collins DA, Kasperbauer JL, Strome SE, Reading CC, Hay ID, Lowe VJ.
    Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
    [Abstract] [Full Text] [Related]

  • 8. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT.
    Keidar Z, Engel A, Hoffman A, Israel O, Nitecki S.
    J Nucl Med; 2007 Aug; 48(8):1230-6. PubMed ID: 17631553
    [Abstract] [Full Text] [Related]

  • 9. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD, Krause BJ, Heusner TA, Boy C, Bockisch A, Antoch G.
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [Abstract] [Full Text] [Related]

  • 10. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW, Kim JH, Kim SK, Kang KW, Park KW, Choi JI, Lee WJ, Kim CM, Nam BH.
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [Abstract] [Full Text] [Related]

  • 11. Fever of unknown origin: the role of 18F-FDG PET/CT.
    Keidar Z, Gurman-Balbir A, Gaitini D, Israel O.
    J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE.
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
    Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D.
    J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409
    [Abstract] [Full Text] [Related]

  • 16. Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics.
    Chen Z, Li X, Li F, Ouyang Q, Yu T.
    Eur J Radiol; 2010 Sep; 75(3):329-35. PubMed ID: 20576385
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ, Zhang YX, Wei H, Jia Q.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2253-6. PubMed ID: 18001544
    [Abstract] [Full Text] [Related]

  • 20. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
    D'souza MM, Sharma R, Mondal A, Jaimini A, Tripathi M, Saw SK, Singh D, Mishra A, Tripathi RP.
    Nucl Med Commun; 2009 Feb 28; 30(2):117-25. PubMed ID: 19057427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.